Academic publisher SAGE and the American College of Clinical Pharmacology (ACCP) have announced the launch of Clinical Pharmacology in Drug Development (CPDD), a new peer-reviewed journal focused on publishing research findings from drug development studies. This is the ACCP's second scholarly journal having published The Journal of Clinical Pharmacology, a world renowned title that has been published for more than 50 years.
As required by law, the U.S. Food and Drug Administration has recently begun to require the entry of clinical trials in a public registry prior to subject enrollment as a condition of consideration for publication of the trial results. In addition, pharmaceutical and biotechnology companies are being encouraged to publish all clinical trial results. CPDD should facilitate compliance with these requirements, and expand the availability of vitally important information on new drugs and biologics in development.
Clinical Pharmacology in Drug Development encourages the submission of original research papers. Acceptance is determined by scientific rigor and technical soundness rather than perceived importance of the presented results; negative study results are explicitly not summarily rejected.
Clinical Pharmacology in Drug Development is an online-only journal that will only be available in print form for purchase by request. The new journal will be available free of charge to ACCP members.
Search for more pharma related academic journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
